SEB Asset Management AB Acquires Shares of 48,505 Molina Healthcare, Inc $MOH

SEB Asset Management AB purchased a new position in shares of Molina Healthcare, Inc (NYSE:MOH) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 48,505 shares of the company’s stock, valued at approximately $6,466,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Torren Management LLC acquired a new stake in Molina Healthcare during the fourth quarter worth approximately $26,000. MUFG Securities EMEA plc purchased a new stake in Molina Healthcare in the second quarter valued at $48,000. Cromwell Holdings LLC lifted its position in Molina Healthcare by 211.9% in the fourth quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock valued at $32,000 after acquiring an additional 125 shares during the last quarter. Quarry LP acquired a new position in Molina Healthcare in the fourth quarter valued at $32,000. Finally, Triumph Capital Management boosted its stake in Molina Healthcare by 4,625.0% in the fourth quarter. Triumph Capital Management now owns 189 shares of the company’s stock valued at $33,000 after acquiring an additional 185 shares in the last quarter. 98.50% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, CAO Maurice Hebert sold 600 shares of the stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $191.55, for a total transaction of $114,930.00. Following the completion of the transaction, the chief accounting officer directly owned 12,815 shares of the company’s stock, valued at $2,454,713.25. This represents a 4.47% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Jeff D. Barlow sold 17,811 shares of the firm’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the completion of the sale, the insider owned 67,175 shares of the company’s stock, valued at approximately $12,502,611. The trade was a 20.96% decrease in their position. The disclosure for this sale is available in the SEC filing. 1.44% of the stock is owned by insiders.

Molina Healthcare Price Performance

Shares of NYSE MOH opened at $226.74 on Wednesday. The stock has a fifty day moving average price of $205.04 and a 200 day moving average price of $176.37. Molina Healthcare, Inc has a 1-year low of $121.06 and a 1-year high of $244.89. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.63 and a quick ratio of 1.63. The company has a market cap of $11.81 billion, a PE ratio of 67.08 and a beta of 0.74.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.78. The company had revenue of $10.80 billion for the quarter, compared to analysts’ expectations of $10.91 billion. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. Molina Healthcare’s revenue was down 3.1% compared to the same quarter last year. During the same period in the previous year, the company posted $6.08 EPS. Sell-side analysts forecast that Molina Healthcare, Inc will post 5.23 EPS for the current year.

Analysts Set New Price Targets

A number of analysts recently issued reports on MOH shares. Wells Fargo & Company upped their target price on Molina Healthcare from $159.00 to $235.00 and gave the company an “equal weight” rating in a research report on Monday, July 13th. Sanford C. Bernstein set a $286.00 price objective on Molina Healthcare in a research note on Monday, July 13th. TD Cowen increased their price objective on Molina Healthcare from $163.00 to $230.00 and gave the company a “hold” rating in a report on Tuesday, July 14th. Mizuho set a $215.00 target price on shares of Molina Healthcare in a research report on Monday, June 8th. Finally, Morgan Stanley lifted their target price on shares of Molina Healthcare from $146.00 to $167.00 and gave the company an “equal weight” rating in a report on Thursday, June 4th. Three analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $207.06.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.